Table 2.
Medication, n (%) | Integrated Stepped Alcohol Treatment (n=46) | Treatment as Usual (n=49) | p value |
---|---|---|---|
Any alcohol treatment medicationa | |||
Baseline | 6 (12.2) | 3 (6.5) | 0.49 |
Week 24 | 8 (16.3) | 3 (6.5) | 0.14 |
Week 52 | 5 (10.2) | 4 (8.7) | 1.0 |
Disulfiram | |||
Baseline | 0 (0) | 0 (0) | NA |
Week 24 | 0 (0) | 0 (0) | NA |
Week 52 | 0 (0) | 0 (0) | NA |
Acamprosate | |||
Baseline | 0 (0) | 0 (0) | NA |
Week 24 | 0 (0) | 0 (0) | NA |
Week 52 | 0 (0) | 0 (0) | NA |
Naltrexone | |||
Baseline | 0 (0) | 0 (0) | NA |
Week 24 | 2 (4.1) | 0 (0) | 0.50 |
Week 52 | 0 (0) | 0 (0) | NA |
Topiramate | |||
Baseline | 0 (0) | 0 (0) | NA |
Week 24 | 0 (0) | 0 (0) | NA |
Week 52 | 0 (0) | 1 (2.2) | 0.48 |
Baclofen | |||
Baseline | 0 (0) | 1 (2.2) | 0.48 |
Week 24 | 0 (0) | 1 (2.2) | 0.48 |
Week 52 | 0 (0) | 2 (4.4) | 0.23 |
Gabapentin | |||
Baseline | 6 (12.2) | 3 (6.5) | 0.49 |
Week 24 | 7 (14.3) | 3 (6.5) | 0.32 |
Week 52 | 5 (10.2) | 2 (4.4) | 0.44 |
. Based on receipt of disulfiram, acamprosate, naltrexone, topiramate, baclofen and/or gabapentin.